Rockwell Medical, Inc. (RMTI) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 17.34B | 18.35M | 15.93M | 16.07M | 18.91M | 24.66M | 28.32M | 25.83M | 22.68M | 22.09M | 23.77M | 18.08M |
| Revenue Growth % | 91556.97% | -25.62% | -43.75% | -37.79% | -16.59% | 11.64% | 19.12% | 42.88% | 15.29% | 14.39% | 27.18% | -3.22% |
| Cost of Goods Sold | 14.44B | 14.47M | 13.65M | 13.57M | 15.87M | 21.03M | 22.08M | 21.28M | 19.61M | 19.22M | 21.57M | 17.05M |
| COGS % of Revenue | 83.29% | 78.86% | 85.73% | 84.43% | 83.92% | 85.28% | 77.97% | 82.39% | 86.49% | 87.01% | 90.74% | 94.29% |
| Gross Profit | 2.9B | 3.88M | 2.27M | 2.5M | 3.04M | 3.63M | 6.24M | 4.55M | 3.06M | 2.87M | 2.2M | 1.03M |
| Gross Margin % | 16.71% | 21.14% | 14.27% | 15.57% | 16.08% | 14.72% | 22.03% | 17.61% | 13.51% | 12.99% | 9.26% | 5.71% |
| Gross Profit Growth % | 95133.4% | 6.8% | -63.58% | -44.99% | -0.72% | 26.52% | 183.33% | 340.46% | 17.89% | 22.65% | 183.4% | -40.8% |
| Operating Expenses | 4.38B | 4.28M | 3.86M | 3.85M | 4.4M | 4.15M | 4.3M | 4.04M | 4.39M | 3.42M | 3.94M | 3.99M |
| OpEx % of Revenue | 25.25% | 23.31% | 24.21% | 23.97% | 23.27% | 16.83% | 15.2% | 15.62% | 19.35% | 15.47% | 16.57% | 22.08% |
| Selling, General & Admin | 4.38B | 4.28M | 3.86M | 3.85M | 4.4M | 4.15M | 4.3M | 4.04M | 4.37M | 3.25M | 3.44M | 3.83M |
| SG&A % of Revenue | 25.25% | 23.31% | 24.21% | 23.97% | 23.27% | 16.82% | 15.2% | 15.62% | 19.27% | 14.71% | 14.49% | 21.16% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 1K | 0 | 0 | 18K | 168K | 494K | 167K |
| R&D % of Revenue | - | - | - | - | - | 0% | - | - | 0.08% | 0.76% | 2.08% | 0.92% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.48B | -398K | -1.58M | -1.35M | -1.36M | -519K | 1.94M | 515K | -1.32M | -547K | -1.74M | -2.96M |
| Operating Margin % | -8.54% | -2.17% | -9.95% | -8.39% | -7.19% | -2.1% | 6.84% | 1.99% | -5.84% | -2.48% | -7.31% | -16.37% |
| Operating Income Growth % | -108723.53% | 23.31% | -181.82% | -361.94% | -2.72% | 5.12% | 211.46% | 117.4% | 7.22% | 72.18% | 53.16% | 33.98% |
| EBITDA | -1.48B | 148K | -1.52M | -786K | -821K | 24K | 2.48M | 1.06M | -779K | 3K | -1.17M | -2.79M |
| EBITDA Margin % | -8.53% | 0.81% | -9.56% | -4.89% | -4.34% | 0.1% | 8.75% | 4.12% | -3.44% | 0.01% | -4.93% | -15.43% |
| EBITDA Growth % | -180105.72% | 516.67% | -161.44% | -173.87% | -5.39% | 700% | 311.34% | 138.15% | 38.52% | 100.23% | 67.1% | 35.75% |
| D&A (Non-Cash Add-back) | 511K | 546K | 61K | 563K | 539K | 543K | 543K | 549K | 545K | 550K | 564K | 170K |
| EBIT | -1.48B | -268K | -1.47M | -1.22M | -1.24M | -467K | 1.97M | 575K | -1.3M | -404K | -1.46M | -2.91M |
| Net Interest Income | -245K | -242K | -230K | -207K | -211K | -260K | -272K | -223K | -407K | -1.07M | -355K | -346K |
| Interest Income | 37K | 44K | 55K | 69K | 66K | 29K | 30K | 9K | 24K | 42K | 56K | 49K |
| Interest Expense | 282K | 286K | 285K | 276K | 277K | 289K | 302K | 232K | 431K | 1.11M | 411K | 395K |
| Other Income/Expense | -125M | -156K | -169K | -143K | -155K | -237K | -272K | -172K | -407K | -965K | -135K | -346K |
| Pretax Income | -1.6B | -554K | -1.75M | -1.49M | -1.51M | -756K | 1.66M | 343K | -1.73M | -1.51M | -1.87M | -3.31M |
| Pretax Margin % | -9.26% | -3.02% | -11.01% | -9.28% | -8.01% | -3.07% | 5.88% | 1.33% | -7.63% | -6.84% | -7.88% | -18.28% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -1.6B | -554K | -1.75M | -1.49M | -1.51M | -756K | 1.66M | 343K | -1.73M | -1.51M | -1.87M | -3.31M |
| Net Margin % | -9.26% | -3.02% | -11.01% | -9.28% | -8.01% | -3.07% | 5.88% | 1.33% | -7.63% | -6.84% | -7.88% | -18.28% |
| Net Income Growth % | -105840.59% | 26.72% | -205.35% | -534.99% | 12.48% | 50% | 188.89% | 110.38% | 1.09% | 35.99% | 55.32% | 33.46% |
| Net Income (Continuing) | -1.6B | -554K | -1.75M | -1.49M | -1.51M | -756K | 1.66M | 343K | -1.73M | -1.51M | -1.87M | -3.31M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.04 | -0.01 | -0.05 | -0.04 | -0.04 | -0.02 | 0.05 | 0.01 | -0.06 | -0.05 | -0.07 | -0.18 |
| EPS Growth % | 8.33% | 38.7% | -197.47% | - | 24.75% | 56.44% | 175.44% | 104.94% | 54.62% | 78% | 84.55% | 70.97% |
| EPS (Basic) | -0.04 | -0.01 | -0.05 | -0.04 | -0.04 | -0.02 | 0.05 | 0.01 | -0.06 | -0.05 | -0.07 | -0.18 |
| Diluted Shares Outstanding | 39.42M | 39.41M | 36.02M | 34.31M | 34.11M | 32.88M | 32.42M | 32.03M | 29.33M | 28.65M | 27.52M | 18.5M |
| Basic Shares Outstanding | 39.42M | 39.41M | 36.02M | 34.31M | 34.11M | 32.88M | 31.55M | 30.45M | 29.33M | 28.65M | 27.52M | 18.5M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |